CYTOKINETICS INC — Director's Dealing 2016

Feb 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2016-02-23

Reporting Person: WOLFF ANDREW A (SVP & CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-23	Incentive Stock Option (right to buy)	$6.67	A	18425.0	Acquired	2026-02-23	Common Stock (18425)	Direct
2016-02-23	Non-Qualified Stock Option (right to buy)	$6.67	A	21575.0	Acquired	2026-02-23	Common Stock (21575)	Direct

Footnotes

F1: When the ISO and NQ dated 02/23/2016 are combined for a total grant of 40,000 shares, the option shall vest and become exercisable as to 40,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/23/2020.